Cleared Traditional

K120189 - BONETRAP

K120189 is an FDA 510(k) clearance for BONETRAP, manufactured by Berni Farns Incorporated. The device is a Class 2 Gastroenterology & Urology device with product code KNW cleared through the Traditional 510(k) pathway after a 30-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2012
Decision
30d
Days
Class 2
Risk

K120189 is an FDA 510(k) clearance for the BONETRAP. Classified as Instrument, Biopsy (product code KNW), Class II - Special Controls.

Submitted by Berni Farns Incorporated (Fernandina Beach, US). The FDA issued a Cleared decision on February 22, 2012 after a review of 30 days - a notably fast clearance cycle.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.1075 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Berni Farns Incorporated devices

FDA 510(k) Submission Details - K120189

510(k) Number K120189 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 23, 2012
Decision Date February 22, 2012
Days to Decision 30 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
101d faster than avg
Panel avg: 131d · This submission: 30d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

KNW Device Classification - Class 2, Special Controls

Product Code KNW Instrument, Biopsy
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.1075
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Peers - KNW Instrument, Biopsy

All 306
Devices cleared under the same product code (KNW) and FDA review panel - the closest regulatory comparables to K120189.
PRESTO BREAST BIOPSY DEVICE
K120440 · Sontina Medical, LLC · May 2012
MAMMOTOME ELITE BIOPSY SYSTEM
K112411 · Devicor Medical Products, Inc. · Mar 2012
THE ONCONTROL BONE ACCESS AND BONE BIOPSY SYSTEM BY VIDACARE
K113872 · Vidacare Corporation · Mar 2012
SURECORE BIOPSY DEVICE
K102756 · Chest Innovations, Inc. · Nov 2011
CHIBA SONO
K113209 · Pajunk GmbH · Nov 2011
ELITECORE FULL CORE BIOPSY DEVICE 18GAX10CM, 18GAX15CM, 18GAX20, WITH/HILITIER 18GAX10CM , W/HILITER 18GAX15CM
K112945 · Inrad, Inc. · Nov 2011